Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C viruses.

Autor: FLORES, G., JUÁREZ, J. C., MONTORO, J. B., TUSELL, J. M., ALTISENT, C., JUSTE, C., JARDÍ, R.
Zdroj: Haemophilia; Apr1995, Vol. 1 Issue 2, p115-117, 3p
Databáze: Complementary Index
Externí odkaz: